Filter
194
Text search:
Community
Development
Medicinal
Unit
Featured
Recommendations
15
New Publications
59
Language
Document type
No document type
88
Studies & Reports
49
Guidelines
31
Manuals
13
Strategic & Response Plan
7
Training Material
3
Situation Updates
3
Countries / Regions
Kenya
11
Myanmar / Burma
9
India
7
Tanzania
7
Uganda
6
Ethiopia
5
Ghana
5
Zimbabwe
5
Global
5
Nigeria
4
Nepal
4
South Africa
4
Bangladesh
4
Malawi
4
Rwanda
3
Indonesia
3
Botswana
3
Western and Central Europe
3
Liberia
2
Cameroon
2
Philippines
2
Cambodia
2
Thailand
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
South–East Asia Region
2
Latin America and the Carribbean
2
Burkina Faso
1
Sierra Leone
1
Senegal
1
Haiti
1
Zambia
1
Mozambique
1
Peru
1
Brazil
1
Ukraine
1
Lesotho
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Asia
1
Africa
1
Fiji
1
Eastern Europe
1
Albania
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
99
Public Health
7
Clinical Guidelines
6
Pharmacy & Technologies
5
Women & Child Health
3
Key Resources
3
Capacity Building
1
Toolboxes
AMR
32
Pharmacy
23
COVID-19
12
Planetary Health
11
HIV
10
NTDs
6
Mental Health
5
TB
4
Rapid Response
3
Global Health Education
3
Caregiver
2
Disability
1
Ebola & Marburg
1
Cholera
1
Refugee
1
Zika
1
Malaria
1
2.0 Rapid Response
1
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
In aquaculture, antibiotics have been used mainly for therapeutic purposes and as prophylactic agents. The contribution to antimicrobial resistance of antibiotics used in aquaculture is reviewed here, using a risk analysis framework. Some recommendations on responsible conduct in this context are pr
...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate
...
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to
...
A cross-sectional descriptive study design covering all states and regions was undertaken to:
1) To assess availability, utilization and supply chain management system for RH commodities at different levels of health facilities,
2) To assess quality of RH services with emphasis on family ...
1) To assess availability, utilization and supply chain management system for RH commodities at different levels of health facilities,
2) To assess quality of RH services with emphasis on family ...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to
...
